1.070CAD0.00%Mkt Cap: 8.13M $P/E: —2d ago
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa recepto…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap8.13M $
Enterprise Value7.59M $
Revenue (TTM)22.81M $
Gross Profit8.56M $
Net Income (TTM)-5.17M $
Revenue/Share2.186 USD
Last Price1.070 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA58469E4085
Valuation
P/E (Trailing)—
P/E (Forward)-3.45
PEG0.17
EV/EBITDA-2.14
EV/Revenue0.33
P/S0.36
P/B0.88
EPS (TTM)-0.65
EPS (Forward)-0.31
52W Range
0.850038% of range1.430
52W High1.430 CAD
52W Low0.8500 CAD
Profitability
Gross Margin40.71%
Oper. Margin-4.62%
EBITDA Margin-15.59%
Profit Margin-24.60%
ROE-54.98%
ROA-28.45%
Growth
Revenue Growth44.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-407.83K $
CapEx (TTM)—
FCF Margin-3.15%
FCF Yield-8.85%
Net Debt-538.18K $
Net Debt/EBITDA0.15
Balance Sheet
Debt/Equity0.07
Current Ratio1.04
Quick Ratio0.70
Book Value/Sh1.214 CAD
Cash/Share0.1480 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateNov 2, 2012
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.10.44M
Float5.27M
Insiders27.30%
Institutions23.10%
Short Interest
Short Ratio1.4d
Short % Float0.03%
Short % Out.0.02%
Shares Short2.53K
Short (prev mo.)2.54K
Technical
SMA 501.146 (-6.6%)
SMA 2001.155 (-7.3%)
Beta1.04
S&P 52W Chg19.63%
Avg Vol (30d)2.07K
Avg Vol (10d)370
Technical Indicators
RSI (14)39.5
MACD-0.0051
MACD Signal0.0160
MACD Hist.-0.0211
BB Upper1.398 CAD
BB Middle1.161 CAD
BB Lower0.9254 CAD
BB Width40.66%
ATR (14)0.0372 CAD
Vol Ratio (20d)0.00x